25 Mar 2026
Morrison Foerster Adds Life Sciences Partner Kathleen Kean in Boston
"Morrison Foerster welcomes Kathleen Kean as a partner in its Life Sciences Transactions + Licensing and Technology Transactions Groups in Boston; she will work on life sciences licensing, collaborations and commercialization deals."
Kean brings more than 20 years of combined private practice and in-house experience advising biotechnology, pharmaceutical, diagnostics, and medical device companies on complex licensing, commercialization, and multibillion-dollar collaboration and M&A-adjacent transactions. Her life sciences practice encompasses licensing arrangements, collaboration agreements, pre-clinical, clinical and commercial contracts, mergers and acquisitions, corporate restructuring transactions, and IP migration transactions. She routinely acts as outside general counsel for biotech companies, managing their licensing and contract needs.
Kean joins Morrison Foerster from another leading global firm, where she led numerous high-profile life sciences transactions. Earlier in her career she served as in-house counsel at two Boston-based global biotech and technology corporations. She is entering Morrison Foerster at the partner level, and her arrival is described as adding immediate senior-level depth and further expanding the firm’s life sciences transactions and licensing capabilities.